Opinion

Video

Novel Investigational Approaches For the Treatment of Neovascular AMD

Author(s):

Paul Hahn, MD, PhD, FASRS,Michael Cohen, MD, FAAO

Dr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.

1:00 Retina specialists’ wish list for innovative therapies

6:40 Home OCT

8:43 Extending treatment intervals beyond four months

9:40 Therapies in the pipeline

15:00 Need for long-term retinal fluid suppression

16:00 Gene therapy

22:00 Helping patients facing end-stage vision loss

Related Videos
Aflibercept 8 mg Shows Durability at 3 Years in Wet AMD with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
Aflibercept 8 mg Noninferior for RVO in QUASAR with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
Quan Dong Nguyen, MD: Phase 2 Neptune Trial Advances Brepocitnib for Uveitis | Image Credit: Stanford University
Charles C. Wykoff, MD, PhD: Phase 1b/2a Results on Restoret for DME, nAMD | Image Credit: Retina Consultants of Texas
Christine N. Kay, MD | Image Credit: Atsena Therapeutics
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Arshad Khanani, MD: First Results from Fellow Eye Dosing of RGX-314 in nAMD | Image Credit: Sierra Eye Associates
Related Content
Sozinibercept Topline Results Expected in Q2 After COAST Trial Completion| Image Credit: Opthea
February 19th 2025

Sozinibercept Topline Results Expected in Q2 After COAST Trial Completion

Connor Iapoce
Ep 16: A Look at Qlosi for Presbyopia with Elad Kedar, MBA| Image Credit: HCPLive
January 28th 2025

New Insight: A Look at Qlosi for Presbyopia with Elad Kedar, MBA

Veeral Sheth, MD, MBA, FASRS, FACS Connor Iapoce
FDA Grants RMAT Designation to RPESC-RPE-4W Transplantation for Dry AMD | Image Credit: US Food and Drug Administration
February 18th 2025

FDA Grants RMAT Designation to RPESC-RPE-4W Transplantation for Dry AMD

Connor Iapoce
New Insight: A Look at Corneal Transplant Alternatives w/ John Sheets, PhD | Image Credit: HCPLive
September 5th 2024

New Insight: A Look at Corneal Transplant Alternatives w/ John Sheets, PhD

Connor Iapoce
FDA Approves Expanded Label for Avacincaptad Pegol | Image Credit: US Food and Drug Administration
February 13th 2025

FDA Expands Dosing Label for Avacincaptad Pegol for Geographic Atrophy

Connor Iapoce
Ophthalmology Month in Review: January 2025 | Image Credit: HCPLive
February 6th 2025

Ophthalmology Month in Review: January 2025

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.